Your browser doesn't support javascript.
loading
Integrated Capecitabine-Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study.
Soulen, Michael C; Teitelbaum, Ursina R; Mick, Rosemarie; Eads, Jennifer; Mondschein, Jeffrey I; Dagli, Mandeep; van Houten, Diana; Damjanov, Nevena; Schneider, Charles; Cengel, Keith; Metz, David C.
Afiliação
  • Soulen MC; Neuroendocrine Tumor Program, Division of Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. Michael.soulen@pennmedicine.upenn.edu.
  • Teitelbaum UR; Neuroendocrine Tumor Program, Department of Radiology, Abramson Cancer Center, University of Pennsylvania, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA, 19104, USA. Michael.soulen@pennmedicine.upenn.edu.
  • Mick R; Neuroendocrine Tumor Program, Division of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Eads J; Department of Biostatistics, Epidemiology and Informatics, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Mondschein JI; Neuroendocrine Tumor Program, Division of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Dagli M; Neuroendocrine Tumor Program, Division of Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • van Houten D; Neuroendocrine Tumor Program, Division of Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Damjanov N; Neuroendocrine Tumor Program, Division of Interventional Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Schneider C; Neuroendocrine Tumor Program, Division of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Cengel K; Neuroendocrine Tumor Program, Division of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Metz DC; Neuroendocrine Tumor Program, Division of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Cardiovasc Intervent Radiol ; 47(1): 60-68, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38057498
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article